Is Higher Adherence Required for Women Using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for Human Immunodeficiency Virus (HIV) Preexposure Prophylaxis?

Journal Article Accepted manuscript Is Higher Adherence Required for Women using Oral Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Preexposure Prophylaxis? Get access Xin Niu, Xin Niu Department of Epidemiology, University of Washington, Seattle, Washington, USA Corresponding author: Xin Niu, 800 NE 42nd St, Apt 207, Seattle, WA 98195 (nealxin@uw.edu) https://orcid.org/0000-0002-9136-3434 Search for other works by this author on: Oxford Academic PubMed Google Scholar Paul K Drain Paul K Drain Department of Epidemiology, University of Washington, Seattle, Washington, USADepartment of Global Health, University of Washington, Seattle, Washington, USADepartment of Medicine, University of Washington, Seattle, Washington, USA Alternate corresponding author: Paul K. Drain, International Clinical Research Center, 325 9th Ave, Harborview Medical Center, Box 359927, Seattle, WA 98104-2499 (pkdrain@uw.edu) Search for other works by this author on: Oxford Academic PubMed Google Scholar Clinical Infectious Diseases, ciad485, https://doi.org/10.1093/cid/ciad485 Published: 17 August 2023 Article history Received: 18 July 2023 Accepted: 14 August 2023 Published: 17 August 2023